Molecular Breast Imaging
Molecular Breast Imaging (MBI) using Positron Emission Mammography (PEM) is a new dedicated breast imaging technology that assists in the evaluation of patients with newly diagnosed breast cancer. Like PET imaging, the patient is given an intravenous injection of the radioactive tracer FDG. This tracer will accumulate at a higher level in cells that have a greater metabolic rate and will show the metabolic function of the human body to reveal certain diseases such as cancer.
Imaging is obtained on the PEM scanner in a manner similar to mammography. The PEM detectors are mounted on two compression paddles, with slight compression to immobilize the breast. The close proximity of the detectors to the target organ allows for increased spatial resolution and detection of breast tumors as small as 1.5 to 2.0 mm. PEM is particularly useful in patients with implants, dense breasts and inconclusive mammogram findings.
Benefits of molecular breast imaging:
- High diagnostic accuracy for breast lesions
- Detects breast cancer as small as 1.5 to 2.0 mm
- Image quality is not compromised by dense breasts, fibrocystic breasts or implants
- No hard breast compression is needed
To schedule a molecular breast scan, call 1-888-738-3211 or 916-737-3211.